首页/数据集/Bortezomib inhibits mTOR pathway in multiple myeloma cells via induced expression of REDD1.

Bortezomib inhibits mTOR pathway in multiple myeloma cells via induced expression of REDD1.

ChEBI2010-02-14 更新2026-07-21 收录

多发性骨髓瘤治疗

信号通路抑制

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-11866 数据链接链接失效反馈

官方服务：

资源简介：

Bortezomib inhibits mTOR pathway in multiple myeloma cells via induced expression of REDD1.

应用场景：

创建时间：

2010-02-14

横纹肌肉瘤

信号通路抑制

Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma with poor prognosis. RMS frequently show Hedgehog (HH) pathway activity, which is predominantly seen in the embryonal subtype (E

NIAID Data Ecosystem90

Supplementary Material for: Long-Term Effectiveness and Safety of Isatuximab in Combination with Pomalidomide and Dexamethasone in a Japanese Patient with Refractory Multiple Myeloma and 1q21 Amplification: A Case Report

多发性骨髓瘤治疗

药物疗效评估

Introduction: In the ICARIA-MM trial, isatuximab plus pomalidomide-dexamethasone (Pd) significantly prolonged progression-free survival, compared with Pd alone, in patients with relapsed or refractory

DataCite Commons2025-01-24 更新80

Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed myeloma multiple? An overview of systematic reviews

多发性骨髓瘤治疗

循证医学

Apêndices da revisão sistemática.

DataCite Commons2023-03-22 更新50

Supplementary Table_S1: Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system.xlsx

医疗成本分析

多发性骨髓瘤治疗

Supplementary Figure 1 . Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system This table contains the Anatomical The

DataCite Commons2024-05-16 更新90

Patient characteristics and clinical features.

多发性骨髓瘤治疗

自体干细胞移植

ABSCT: autologous stem cell transplantation AUY: NVP-AUY922 BPT: bortezomib, prednisone and thalidomide Dexa: dexamethasone HD-Melphalan: high dose melphalan MPV: melphalan, prednisone and bortezomib

NIAID Data Ecosystem60

Bortezomib inhibits mTOR pathway in multiple myeloma cells via induced expression of REDD1.

资源简介：

相关数据集